Arkolith/Insider Trading/PMVP/Form 4

Gallagher Carol Giltner

DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Jun 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 7, 2024Gift(G)68K—$068K
Jun 7, 2024Gift(G)68K—$00
Jun 6, 2024Grant(A)68K—$068K

Transaction Codes

G
Gift
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-016208) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML